PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Detail   |   Print    Next page > 
     
INTCO Medical Reports 40.6% H1 2026 Revenue Growth, Expands World's Largest Disposable Glove Capacity to 107 Billion Pieces
2026-08-29T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
LifeTech Scientific Corporation Announces 2026 Interim Results
2026-08-29T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Formosa Pharmaceuticals Files Clinical Trial Application for TSY-110, an Antibody-Drug Conjugate Biosimilar Targeting HER2-Positive Breast Cancers
2026-08-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
HiRO and Differentia Biotech Forge Strategic Alliance to Redefine Clinical Trial Design Through AI-Powered Simulation
2026-08-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma
2026-08-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering
2026-08-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
InxMed Announces Publication in The Lancet Oncology Featuring Encouraging Antitumor Activity of Ifebemtinib in Combination with Garsorasib in Previously Treated Metastatic Colorectal Cancer (CRC) Harboring KRAS G12C Mutation
2026-08-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Tigermed Announces 2026 Interim Results
2026-08-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
DualityBio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation ADCs Built on DualityBio's DUPAC Novel-Payload Platform
2026-08-28T    Biotechnology   Medical/Pharmaceuticals 
Akeso 2026 Interim Results: Strong Commercialization Momentum; IO2.0+ Global Strategy Redefining Clinical Standards; Bispecific Advancement in ADC, I&I and Alzheimer's
2026-08-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved